Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) EBIT Margin (2016 - 2025)

Phibro Animal Health has reported EBIT Margin over the past 14 years, most recently at 13.46% for Q4 2025.

  • Quarterly results put EBIT Margin at 13.46% for Q4 2025, up 520.0% from a year ago — trailing twelve months through Dec 2025 was 11.53% (up 415.0% YoY), and the annual figure for FY2025 was 8.52%, up 328.0%.
  • EBIT Margin for Q4 2025 was 13.46% at Phibro Animal Health, down from 14.09% in the prior quarter.
  • Over the last five years, EBIT Margin for PAHC hit a ceiling of 14.09% in Q3 2025 and a floor of 0.31% in Q3 2023.
  • Median EBIT Margin over the past 5 years was 8.13% (2022), compared with a mean of 8.11%.
  • Biggest five-year swings in EBIT Margin: crashed -620bps in 2023 and later skyrocketed 729bps in 2025.
  • Phibro Animal Health's EBIT Margin stood at 9.58% in 2021, then crashed by -32bps to 6.48% in 2022, then fell by -3bps to 6.28% in 2023, then skyrocketed by 31bps to 8.26% in 2024, then skyrocketed by 63bps to 13.46% in 2025.
  • The last three reported values for EBIT Margin were 13.46% (Q4 2025), 14.09% (Q3 2025), and 8.9% (Q2 2025) per Business Quant data.